Dr. Cori Richards-Zawacki is an Associate Professor in the Department of Biological Sciences and Director of the Pymatuning Lab of Ecology at the University of Pittsburgh. Cori studies topics in ecology, evolutionary biology, behavior, and conservation in frogs. In particular, she is working to understand how frogs use different body forms, colors, and other features to survive partially on land and partially in water. When she’s not working and doing research, Cori enjoys spending time outside with her husband and two young daughters. She likes to play soccer, hike, go mountain biking, and do other outdoor activities. Cori received her Bachelor’s degree in engineering and biology as well as her PhD in ecology and evolutionary biology both from the University of Michigan. She conducted postdoctoral research at the Smithsonian Institute and the University of California, Berkeley. Cori next served on the faculty at Tulane University prior to joining the faculty at the University of Pittsburgh in 2015. In our interview, Cori shares more about her life and science.

Direct download: 507_Cori_Richards_Zawacki_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Jim Doherty is Chief Research Officer at Sage Therapeutics, a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-altering central nervous system disorders. Jim and his colleagues are focused on developing new treatments for different brain disorders including psychiatric, neurodegenerative, and movement disorders. Outside of science, Jim enjoys traveling, seeing cool new sites, and exploring the history of different places with his wife and two kids. He also enjoys participating in a variety of team sports like golf, softball, and ultimate frisbee leagues. Jim received his B.A. in biology from the University of Delaware and his Ph.D. in neuroscience from Georgetown University. Next, he conducted postdoctoral research at Emory University Medical School and subsequently served on the faculty at Emory for about two years. Prior to joining the team at Sage in 2014, Jim worked for about eleven years at AstraZeneca Pharmaceuticals. In our interview Jim shares more about his life and science.

Direct download: 506_Jim_Doherty_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Neil Solomons is Chief Medical Officer and Co-Founder of Aurinia Pharmaceuticals, a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. Neil is working to develop a drug to treat a rare autoimmune disease called lupus nephritis. In lupus nephritis, there is inflammation of the kidneys that can result in kidney failure, need for dialysis, or kidney transplant. Currently, there are no FDA-approved therapies for this disease, and the team at Aurinia is excited to be in the final stages of developing a drug called Voclosporin to treat lupus nephritis. Outside of research, Neil is an obsessive soccer fan, and he has been avidly watching English Premier League games since he was a child. He also enjoys playing the guitar and spending time with his family. Neil was awarded his Medical Degree from the University of London’s Guys Hospital Medical School. Afterwards, he worked as a physician in London and completed specialist training in anesthesia and intensive care. Neil held positions at Roche Pharmaceuticals, Aspreva Pharmaceuticals, and Vifor Pharma before co-founding Aurinia. In our interview Neil will tell us more about his life and science.

Direct download: 505_Neil_Solomons_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Anne Fung is the Global Development Lead for the Port Delivery System with Ranibizumab and Lucentis at Genentech. She is also a practicing retina specialist and researcher at Pacific Eye Associates and California Pacific Medical Center in San Francisco. Macular degeneration is a degenerative condition of a portion of the retina in the eye. This disease generally affects older adults. While there are some amazing medicines that can help people with macular degeneration, these medicines must be injected into the eye every 4-6 weeks. Anne is working on a tiny implant that serves as a reservoir for medicine so it can be slowly released over 6 months or more. They are currently investigating how long this implant can effectively treat the disease. Outside of science, Anne loves practicing yoga, as well as reading, listening to podcasts, and listening to audiobooks on a variety of topics including business, organizations, and psychology. Anne received her undergraduate degree from Wellesley College and her Medical Degree from Cornell University. She completed her residency in ophthalmology at Stanford University School of Medicine and then pursued a Medical Retina Fellowship at the Bascom Palmer Eye Institute and the University of Miami Miller School of Medicine. Anne worked in clinical practice for ten years before joining the team at Genentech in 2014. Anne is a Board Certified Ophthalmologist and is a Fellow of the American Academy of Ophthalmology. In our interview she shares more about her life and science.

Direct download: 504_Anne_Fung_Final.mp3
Category:general -- posted at: 3:00am EDT






June 2019
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29